Suchergebnisse - "He, Aili"

PubPharm (139)

1

Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia

enthalten in: Journal of cancer research and clinical oncology | 2024

von Li, F. | Miao, J. | Liu, R. | +2

2

Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia

enthalten in: Journal of cancer research and clinical oncology | 2024

von Li, F. | Miao, J. | Liu, R. | +2

3

BATF promotes extramedullary infiltration through TGF-β1/Smad/MMPs axis in acute myeloid leukemia

enthalten in: Molecular carcinogenesis | 2024

von Zhang, R. | Miao, J. | Zhai, M. | +10

4

Outcomes in patients with multiple myeloma receiving salvage treatment after BCMA-specific CAR-T therapy : A retrospective analysis of LEGEND-2

enthalten in: British journal of haematology | 2024

von Liu, R. | Yang, R. | Xu, X. | +8

5

Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström's Macroglobulinemia : A Multicenter, Single-Arm, Phase 4 Study

enthalten in: Advances in therapy | 2024

von Yi, S. | Cai, Z. | Hu, Y. | +10

6

Circular RNA circXPO1 Promotes Multiple Myeloma Progression by Regulating miR-495-3p/DNA Damage-Induced Transcription 4 Axis

enthalten in: DNA and cell biology | 2024

von Li, F. | Liu, J. | Miao, J. | +6

7

Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma : a multicenter, open-label, single-arm trial

enthalten in: Annals of hematology | 2024

von Zhou, H. | Wang, Y. | Chen, J. | +34

8

Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial

enthalten in: Annals of hematology | 2023

von Zhou, H. | Wang, Y. | Chen, J. | +34

9

Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström’s Macroglobulinemia: A Multicenter, Single-Arm, Phase 4 Study

enthalten in: Advances in therapy | 2023

von Yi, S. | Cai, Z. | Hu, Y. | +10

10

Real-world results of venetoclax combined with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukemia

enthalten in: Hematology (Amsterdam, Netherlands) | 2023

von Xu, X. | Liu, R. | He, A. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]